INTRICON CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2019-11-04: Form 8-K; Period of report 2019-11-04; Description 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; Details 2.02.
- 2019-08-06: Form 8-K; Period of report 2019-08-06; Description 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; Details 2.02.
- 2019-07-18: Form 8-K; Period of report 2019-07-12; Description 1.01 Entry into a Material Definitive Agreement; 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; Details 1.01.
- 2019-07-02: Form 8-K/A; Period of report 2019-06-25; Description 2.05 Costs Associated with Exit or Disposal Activities; 2.06 Material Impairments; 7.01 Regulation FD Disclosure; Details 2.05.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2019-11-04 | 8-K | 2019-11-04 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 The following information is being provided pursuant to Item 2.02. 7.01 The following information is being provided pursuant to Item 7.01. | intricon192140_8k.htm |
| 2019-08-06 | 8-K | 2019-08-06 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 The following information is being provided pursuant to Item 2.02. 7.01 The following information is being provided pursuant to Item 7.01. | intricon191619_8k.htm |
| 2019-07-18 | 8-K | 2019-07-12 | 1.01 Entry into a Material Definitive Agreement; 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 1.01 The Supply Agreement governs the terms of manufacture by the Company for Medtronic of Medtronic’s wireless continuous glucose monitors (“CGM”), sensor assemblies and accessories associated with Medtronic’s insulin pump and CGM systems, including, among other matters, order, shipping and delivery terms, pricing and payment terms, production and quality, regulatory compliance, confidentiality, intellectual property rights, product warranties, representations, indemnification and termination. 2.02 The following information is being provided pursuant to Item 2.02. 7.01 On July 18, 2019, the Company issued a press release announcing preliminary, unaudited revenue for the second quarter 2019 and revised its revenue outlook for full year 2019. | intricon191493_8k.htm |
| 2019-07-02 | 8-K/A | 2019-06-25 | 2.05 Costs Associated with Exit or Disposal Activities; 2.06 Material Impairments; 7.01 Regulation FD Disclosure | 2.05 On June 25, 2019, the officers of the Company approved the closing of its IntriCon UK Limited subsidiary, which is expected to reduce costs by approximately $1.0 million annually. 2.06 The information set forth above in Item 2.05 is hereby incorporated into Item 2.06 by reference. 7.01 On July 2, 2019, the Company issued a press release concerning its UK Limited subsidiary. | intricon191429_8ka.htm |
| 2019-07-01 | 8-K | 2019-06-25 | 2.05 Costs Associated with Exit or Disposal Activities; 2.06 Material Impairments | 2.05 On June 25, 2019, the officers of IntriCon Corporation (the “Company”) approved the closing of its IntriCon UK Limited subsidiary, which is expected to reduce costs by approximately $1.0 million annually. 2.06 The information set forth above in Item 2.05 is hereby incorporated into Item 2.06 by reference. | intricon191414_8k.htm |
| 2019-05-08 | 8-K | 2019-05-01 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 (a) The annual meeting of shareholders of IntriCon Corporation (“IntriCon”) was held on May 1, 2019. | intricon191068_8k.htm |
| 2019-04-29 | 8-K | 2019-04-26 | 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure | 2.02 The following information is being provided pursuant to Item 2.02. 5.02 (b) As disclosed in the proxy statement of IntriCon Corporation (the “Company”) filed with the Securities and Exchange Commission on March 14, 2019, referred to as the 2019 proxy statement, Michael J. McKenna will retire as a director following the annual meeting of shareholders on May 1, 2019. 7.01 The following information is being provided pursuant to Item 7.01. | intricon190973_8k.htm |
| 2019-04-22 | 8-K | 2019-04-17 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 2.03 Amendment of Loan and Security Agreement. | intricon190866_8k.htm |
| 2019-02-19 | 8-K | 2019-02-19 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 The following information is being provided pursuant to Item 2.02. 7.01 The following information is being provided pursuant to Item 7.01. | intricon190347_8k.htm |